Home PR Newswire
Monday, June 8, 2026
23.2
C
Bengaluru
Hot topics
MedicinMan Indian Pharma Digital Adoption Survey
Smaller Indian pharma companies bore the strongest impact from...
Mounjaro to Orforglipro: Lilly’s $6 Billion Bet on the Next GLP‑1 Revolution
Eli Lilly is in a rare position. Its GLP-1...
Indian Oncology: An Unasked Question, the Challenges Ahead
A Brief History of Scale and an Unasked Question
In...
Sales Force Strategy in the Digital World
Does Your Company Have a Well Thought-out Strategy on...
Eli Lilly’s Acquisition of Adverum Signals Focus on Gene Therapies to Redefine Eye Care
Eli Lilly’s planned acquisition of Adverum Biotechnologies is a...
Sun Pharma’s Genius Dealmaking — Dilip Shanghvi, Indian Pharma’s Shrewdest Businessman
Dilip Shanghvi didn’t begin in a lab or inherit...
Will Paras IPO Disrupt Non-Metro Hospitals Like Mankind Pharma?
India's next healthcare opportunity may not be in the...
Not Everything is a Problem to be Solved
As professionals, we are conditioned to be "fixers." We...
Indian Pharma: The Marketing – Field Disconnect and Its Remedy
The Anomaly
Unless you learn to accept that chaos is...
The Tragic Genius of Yellapragada Subbarow
Every day, doctors worldwide prescribe methotrexate, doxycycline, and folic...
Sun Pharma’s Genius Dealmaking — Dilip Shanghvi, Indian Pharma’s Shrewdest Businessman
Dilip Shanghvi didn’t begin in a lab or inherit...
Will Paras IPO Disrupt Non-Metro Hospitals Like Mankind Pharma?
India's next healthcare opportunity may not be in the...
Not Everything is a Problem to be Solved
As professionals, we are conditioned to be "fixers." We...
Indian Pharma: The Marketing – Field Disconnect and Its Remedy
The Anomaly
Unless you learn to accept that chaos is...
The Tragic Genius of Yellapragada Subbarow
Every day, doctors worldwide prescribe methotrexate, doxycycline, and folic...
Sun Pharma’s Genius Dealmaking — Dilip Shanghvi, Indian Pharma’s Shrewdest Businessman
Dilip Shanghvi didn’t begin in a lab or inherit...
Will Paras IPO Disrupt Non-Metro Hospitals Like Mankind Pharma?
India's next healthcare opportunity may not be in the...
Not Everything is a Problem to be Solved
As professionals, we are conditioned to be "fixers." We...
Indian Pharma: The Marketing – Field Disconnect and Its Remedy
The Anomaly
Unless you learn to accept that chaos is...
The Tragic Genius of Yellapragada Subbarow
Every day, doctors worldwide prescribe methotrexate, doxycycline, and folic...
Sun Pharma’s Genius Dealmaking — Dilip Shanghvi, Indian Pharma’s Shrewdest Businessman
Dilip Shanghvi didn’t begin in a lab or inherit...
Will Paras IPO Disrupt Non-Metro Hospitals Like Mankind Pharma?
India's next healthcare opportunity may not be in the...
Not Everything is a Problem to be Solved
As professionals, we are conditioned to be "fixers." We...
Indian Pharma: The Marketing – Field Disconnect and Its Remedy
The Anomaly
Unless you learn to accept that chaos is...
The Tragic Genius of Yellapragada Subbarow
Every day, doctors worldwide prescribe methotrexate, doxycycline, and folic...
Hot topics
Interview with Ajit Singh, Chairman, ACG
Special interview with the Chairman of ACG and an invitation to "Pharmaceutical Marketing in the New Age" - a conference presented by ACG in partnership with MedicinMan
Hype and Happening: GLP-1 Growth Story – Follow the Patient, not the Primary Sales
Is Obesity (Drugs) Masking Underlying (Metabolic) Risk Factors in...
DeepSeek – A Precursor to Patent Disruption?
The rise of open-source platforms, such as China’s DeepSeek...
Can Indian Doctors and Patients Trust Generics Over Branded Generics? ...
The ongoing debate around branded versus generic medicines in...
Trump’s 100% Drug Tariffs Explained: The Surprising Opportunity for India
How the 2026 U.S. tariff action on branded drugs...
Sun Pharma’s Genius Dealmaking — Dilip Shanghvi, Indian Pharma’s Shrewdest Businessman
Dilip Shanghvi didn’t begin in a lab or inherit...
Will Paras IPO Disrupt Non-Metro Hospitals Like Mankind Pharma?
India's next healthcare opportunity may not be in the...
Not Everything is a Problem to be Solved
As professionals, we are conditioned to be "fixers." We...
Indian Pharma: The Marketing – Field Disconnect and Its Remedy
The Anomaly
Unless you learn to accept that chaos is...
The Tragic Genius of Yellapragada Subbarow
Every day, doctors worldwide prescribe methotrexate, doxycycline, and folic...
Sun Pharma’s Genius Dealmaking — Dilip Shanghvi, Indian Pharma’s Shrewdest Businessman
Dilip Shanghvi didn’t begin in a lab or inherit...
Will Paras IPO Disrupt Non-Metro Hospitals Like Mankind Pharma?
India's next healthcare opportunity may not be in the...
Not Everything is a Problem to be Solved
As professionals, we are conditioned to be "fixers." We...
Indian Pharma: The Marketing – Field Disconnect and Its Remedy
The Anomaly
Unless you learn to accept that chaos is...
The Tragic Genius of Yellapragada Subbarow
Every day, doctors worldwide prescribe methotrexate, doxycycline, and folic...
Sun Pharma’s Genius Dealmaking — Dilip Shanghvi, Indian Pharma’s Shrewdest Businessman
Dilip Shanghvi didn’t begin in a lab or inherit...
Will Paras IPO Disrupt Non-Metro Hospitals Like Mankind Pharma?
India's next healthcare opportunity may not be in the...
Not Everything is a Problem to be Solved
As professionals, we are conditioned to be "fixers." We...
Indian Pharma: The Marketing – Field Disconnect and Its Remedy
The Anomaly
Unless you learn to accept that chaos is...
The Tragic Genius of Yellapragada Subbarow
Every day, doctors worldwide prescribe methotrexate, doxycycline, and folic...
Sun Pharma’s Genius Dealmaking — Dilip Shanghvi, Indian Pharma’s Shrewdest Businessman
Dilip Shanghvi didn’t begin in a lab or inherit...
Will Paras IPO Disrupt Non-Metro Hospitals Like Mankind Pharma?
India's next healthcare opportunity may not be in the...
Not Everything is a Problem to be Solved
As professionals, we are conditioned to be "fixers." We...
Indian Pharma: The Marketing – Field Disconnect and Its Remedy
The Anomaly
Unless you learn to accept that chaos is...
The Tragic Genius of Yellapragada Subbarow
Every day, doctors worldwide prescribe methotrexate, doxycycline, and folic...
MedicinMan was launched in 2011 as India’s 1st Magazine dedicated to the cause of Field Force Excellence in Pharma and Devices.
Read More
Headlines
Sun Pharma’s Genius Dealmaking — Dilip Shanghvi, Indian Pharma’s Shrewdest Businessman
Dilip Shanghvi didn’t begin in a lab or inherit...
Will Paras IPO Disrupt Non-Metro Hospitals Like Mankind Pharma?
India's next healthcare opportunity may not be in the...
Not Everything is a Problem to be Solved
As professionals, we are conditioned to be "fixers." We...
Indian Pharma: The Marketing – Field Disconnect and Its Remedy
The Anomaly
Unless you learn to accept that chaos is...
Newsletter
Get important news delivered directly to your inbox and stay connected!